Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL‐2‐dependent proliferation of CTLL‐2 T cells
暂无分享,去创建一个
T. Rademacher | P. Delves | I. Roitt | B. Chain | B. Chain | T. Lund | I. Roitt | P. Free | I. Vojnović | P. Delves | T. Rademacher | N. Kvirkvelia | T. Warner | V. Athié-Morales | N. Rayment | Benjamin M. Chain | Paul Free | NB Rayment | Thomas W. Rademacher | Ivan Roitt
[1] C. Leu,et al. Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). , 2001, Molecular pharmacology.
[2] Xinchun Zhou,et al. Prostaglandin E2 Suppressed IL-15-Mediated Human NK Cell Function Through Down-Regulation of Common γ-Chain1 , 2001, The Journal of Immunology.
[3] O. Thellin,et al. Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months. , 2000, Current opinion in immunology.
[4] J. S. Hunt,et al. Uterine leukocytes: key players in pregnancy. , 2000, Seminars in cell & developmental biology.
[5] P. Johnson,et al. Leucocyte populations and cytokine regulation in human uteroplacental tissues. , 2000, Biochemical Society transactions.
[6] G. Chaouat,et al. Regulation of T‐Cell Activities at the Feto‐Placental Interface—by Placenta? , 1999, American journal of reproductive immunology.
[7] P. Arck,et al. Murine T cell determination of pregnancy outcome. , 1999, Cellular immunology.
[8] Saito,et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia , 1999, Clinical and experimental immunology.
[9] C. Turck,et al. Prostaglandin E2 enhancement of interferon-gamma production by antigen-stimulated type 1 helper T cells. , 1999, Cellular immunology.
[10] J. Finke,et al. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway. , 1999, Blood.
[11] P. Kalinski,et al. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. , 1999, Journal of immunology.
[12] S. Narumiya,et al. Prostanoid receptors: structures, properties, and functions. , 1999, Physiological reviews.
[13] D. Munn,et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. , 1998, Science.
[14] T. Gurlo,et al. PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells. , 1998, Cytokine.
[15] H. Klocker,et al. Prostaglandin E2 and Tumor Necrosis Factor ␣ Cooperate to Activate Human Dendritic Cells: Synergistic Activation of Interleukin 12 Production , 1997 .
[16] R. Raghupathy. Th1-type immunity is incompatible with successful pregnancy. , 1997, Immunology today.
[17] L. Elliott,et al. Costimulation with dexamethasone and prostaglandin E2: a novel paradigm for the induction of T-cell anergy. , 1997, Cellular immunology.
[18] P. Kalinski,et al. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. , 1997, Journal of immunology.
[19] G. Chaouat,et al. Immunoactive products of placenta. VI. Induction of transient murine T cell anergy by a low-molecular-weight compound obtained from supernatants of human placental cultures. , 1997, Cellular immunology.
[20] M. Murakami,et al. Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. , 1997, Biochemical and biophysical research communications.
[21] M. Clerici,et al. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy , 1996, Clinical and experimental immunology.
[22] T. Wegmann,et al. A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. , 1996, Journal of reproductive immunology.
[23] F. Paliogianni,et al. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. , 1996, Cellular immunology.
[24] E. Goetzl,et al. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. , 1996, Biochemistry.
[25] J. Alferink,et al. T Cell Awareness of Paternal Alloantigens During Pregnancy , 1995, Science.
[26] F. Annunziato,et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. , 1995, Journal of immunology.
[27] D. Albert,et al. The effect of cyclic-AMP on the regulation of c-myc expression in T lymphoma cells. , 1995, The Journal of clinical investigation.
[28] D. Brown,et al. Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE. , 1995, Journal of immunology.
[29] T. Roszman,et al. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. , 1994, Cellular immunology.
[30] G. Chaouat,et al. Suppression of local and systemic GVHR by supernatants from human choriocarcinoma cell lines. , 1993, Cellular immunology.
[31] T. Mosmann,et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.
[32] P. Kalinski,et al. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. , 1993, Journal of immunology.
[33] F. Paliogianni,et al. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels. , 1992, Journal of immunology.
[34] G. Chaouat,et al. In vitro and in vivo immunosuppressive effects of supernatants from human choriocarcinoma cell lines. , 1991, Cellular immunology.
[35] C. Deutsch,et al. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits is affected. , 1991, Journal of immunology.
[36] M. Betz,et al. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. , 1991, Journal of immunology.
[37] L. Davis,et al. Delineation of the mechanism of inhibition of human T cell activation by PGE2. , 1990, Journal of immunology.
[38] G. Chaouat,et al. Immunoactive products of human placenta. I. An immunoregulatory factor obtained from explant cultures of human placenta inhibits CTL generation and cytotoxic effector activity. , 1989, Cellular immunology.
[39] P. Lala,et al. Suppression of lymphocyte alloreactivity by early gestational human decidua. II. Characterization of the suppressor mechanisms. , 1988, Cellular immunology.
[40] P. Lala,et al. Suppression of lymphocyte alloreactivity by early gestational human decidua. I. Characterization of suppressor cells and suppressor molecules. , 1988, Cellular immunology.
[41] J. Finke,et al. Downregulation of JAK 3 Protein Levels in T Lymphocytes by Prostaglandin E 2 and Other Cyclic Adenosine Monophosphate-Elevating Agents : Impact on Interleukin-2 Receptor Signaling Pathway , 1999 .
[42] K. Prévost,et al. Prostaglandin E2 promotes the induction of anergy during T helper cell recognition of myelin basic protein. , 1995, Cellular immunology.
[43] K. Hopper,et al. Immunoregulation by macrophages. III. Prostaglandin E suppresses lymphocyte activation but not macrophage effector function during Salmonella enteritidis infection. , 1984, International journal of immunopharmacology.
[44] P. Medawar. Some immunological and endocrinological problems raised by the evolution of viviparity in verte- brates , 1953 .